Introduction
Diabetes mellitus (DM) is a family of metabolic disorders characterized by the presence of chronic hyperglycemia that is either immune-mediated, due to insulin resistance, gestational or due to other causes (environment, genetic defects, infections, and certain drugs) [1] . Corkey [2] defined DM as fasting glucose concentrations of above 7 mmol/l, or above 11mmol/l two hours after ingestion of 75 grams of glucose.
Type 2 diabetes is more prevalent than type 1 diabetes and is associated with a substantially increased risk of macrovascular complications [3] .The prevalence of diabetic vasculopathies is higher in people with poor glycaemic control, longer duration of DM, and associated hypertension and obesity [4] . Gestational diabetes mellitus (GDM) or impaired glucose tolerance which is characterized by a hyperinsulinemic state and a decrease of tissues receptors to insulin, affects between 3-10% of all pregnancies [5] [6] . The consequences of GDM lead to increased prenatal and maternal morbidity and mortality [7] .DM is alluded to be found in every population in the world and epidemiological evidence suggests that, without effective prevention and control programmes, diabetes will likely continue to increase globally [8] .
The metabolic derangements associated with diabetes can adversely influence platelet and vascular endothelial activity, which may contribute to pathogenesis of diabetic angiopathy [9] . Platelets from diabetic subjects show increased reactivity [10] .Vaidyula et al. [11] reported platelet hypereactivity in healthy subjects without diabetes after induction of hyperglycaemia and hyperinsulinaemia. In agreement with previous studies, improved glycemic control has been linked with decreased platelet reactivity [9] .The hyperglycemia at the base of diabetes contributes to greater platelet reactivity through direct effects and by promoting glycation of platelet proteins [3] . One way hyperglycemia can cause platelet hypereactivity is by inducing non-enzymatic glycation of proteins on the surface of the platelet. The glycation decreases membrane fluidity which in turn increases the tendency of platelets to activate [12] . In another mechanism, hyperglycemia increase platelet reactivity by osmotic effect of glucose. According to Schneider [3] , a brief exposure of platelets in vitro to hyperglycemia increased their reactivity. Assert et al. [13] demonstrated that in vivo activation of protein C kinase, being a transduction pathway mediator of platelet activation, is another mechanism by which hyperglycaemia can cause platelet hypereactivity. The final common pathway of platelet activation is platelet aggregation, mediated by the glycoprotein IIb/IIIa receptor (GPIIb/IIIa) platelet-fibrin interaction. Hyperglycaemia leads to release of larger platelets with more GPIb and GPIIb/IIIa receptors and higher thromboxane forming capacity [14] .
In individuals with insulin resistance or insulin deficiency, Insulin normally antagonizes the effect of platelet agonists such as collagen, ADP, epinephrine, and platelet-activating factor [15] . The insulin antagonism is mediated by activation of an inhibitory G protein by insulin receptor substrate (IRS)-1. Insulin resistance reflects impaired insulin signaling, predominantly mediated by IRS. Thus, resistance by the platelet to the effects of insulin (relative insulin deficiency) or absolute deficiency of insulin attenuates insulin mediated antagonism of platelet activation and thereby increases platelet reactivity [3] [16] . Chronic hyperglycaemia, the sine qua non of diabetes causes derangements in many physiological functions related to haemostasis [17] . There is platelet hypereaction and platelet turnover; leading to increased platelet adhesion and aggregation enhanced expression of platelet surface adhesion molecules and receptors [18] . The mean platelet volume, platelet counts and other platelet parameters may significantly aid the identification of diabetics at risk for vascular complications [19] . Platelet counts and mean platelet volume are characteristics of platelet. These are simple and viable indicators of platelet activation and can be used as biomarkers for risk of macrovascular complications in diabetics [5] [20] .
Several reports compared and/or correlate platelet parameters as measure of platelet activity in diabetics and non-diabetics [5] [18] [19] [20] . Platelet count was an unavoidable parameter measured. In view of these, the present study sought to determine the platelet counts among the various diabetic groups and correlate with fasting plasma glucose which is could be an essential marker of haemostatic derangements in diabetes.
II. Methods

Study area
This study was carried out in the Haematology Department, University of Maiduguri Teaching Hospital (UMTH), Maiduguri, Nigeria. UMTH is a major referral medical centre in the North eastern Nigeria, with 500 bed size and sub-specialties in medicine and training of other health care professionals. Maiduguri is the capital of Borno state, which lies on latitude 115 o N and longitude 135 o E, and occupies an area of 50,778 square kilo meters.
Study population
A total of 220 subjects were recruited for this study, which comprises of 120 clinically diagnosed diabetic subjects and 100 non-diabetic subjects as control.
Sample size determination
The sample size was determined from a standard formula for the calculation of sample size. Sample size n = (Z 1-a ) 2 x P (1-P) d 2 Where n = minimum sample size, Z 1-a = value of standard normal deviation which is at 95% confidence level has been found to be 1.96. P= best estimate of the population prevalence obtained from the literature review. d = proportion of sample error in a given population. At prevalence rate of Diabetes mellitus of 8.3% [21] , using 5% precision at 95% confidence level, the minimum sample size n for this study is calculated as follows:
Where Z=1.96, P=8.3%, 0.083 d = 5%, 0.05 Therefore, n= (1.96) 2 x 0.083 x (1-0.0830) 0.05 2 n = 116.9, ≈ 117 The minimum sample size is 117. However, 3 will be added as attrition. n = 120
Sampling technique
A simple random sampling technique was used to recruit subjects who satisfied the inclusion criteria.
Inclusion/ Exclusion criteria
For the control group; subjects with no family history of diabetes mellitus, normal blood pressure, normal plasma glucose level and absence of glucosuria. For case study; subjects were selected based on clinical diagnosis of diabetes mellitus. Individuals with likely confounding factors such as obesity, family history of diabetes, high or low plasma glucose level, glucosuria, physical and medication like Acetyl salicylic acid (ASA) were excluded from being control subjects.
Informed consent
Written informed consent was obtained from all participating subjects. 
Ethical clearance
Variable data
A standard structured questionnaire was used to obtain some demographic information of all participants.
Sample collection
Tourniquet was applied to the upper right arm, and desired area for the sample collection was selected and sterilized using swab soaked in 70% alcohol. 3millilitres of blood, each, was drawn into Oxalate fluoride and EDTA containers. They were well mixed and clearly labeled with the subject's identification number and date as labeled on the questionnaire. The samples in Oxalate fluoride containers were centrifuged at 4000rpm for 10 minutes, plasma was obtained for glucose estimation while the whole blood in the EDTA containers were used for determination of platelet counts.
Glucose estimation
Plasma glucose was determined by the oxidase-peroxidase (enzymatic) colorimetric method as described by Trinder [22] . The testing was conducted based on manufacturers instruction (Randox laboratories, limited, UK).
Platelet count determination
The platelet count was determined by haemocytometer as described by Cheesebrough [23] .
Statistical analysis
Data generated was analysed using Statistical Package for Social Science (SPSS version 20.0 for windows). Students' t-test was used for analysis of differences between means for two groups. Pearson correlations were conducted to determine associations between platelet counts and fasting plasma glucose.
III. Results
A total of 220 subjects; 120 diabetics and 100 non-diabetics were recruited for the study. Out of the 120 diabetic subjects, 42 (35%) were males and 78 (65%) were females (Table I) . Table II shows distribution of diabetic subjects according to types of diabetes. Out of 120 diabetic subjects, 2 (1.7%) were type I diabetes, 101 (84.1%) were type 2 diabetes while 17 (14.2%) were gestational diabetes. The sample size for type 1 diabetics (1.7%) is too small to make any reasonable inference. There was no significant difference (p>0.05) between the means of platelet counts of diabetics and controls; gestational diabetes and controls (315.37±56.13×10 9 cells/l versus 335.98±52.29 ×10 9 cells/l; 325.82±56.78×10 9 cells/l versus 335.98± 52.29×10 9 cells/l) respectively as presented in table III. In our study, the mean platelet counts Was significantly (p<0.05) lower in type 2 diabetics as compared to the gestational diabetics (315.37±56.13×10 9 cells/l versus 325.82±56.78×10 9 cells/l). This is shown in table IV. There was a positive but not significant correlation(r= 0.052; p>0.05) between platelet counts and fasting plasma glucose of diabetic subjects (table V). 
IV. Discussion
Platelet counts and mean platelet volume are characteristics of platelet and simple viable indicators of platelet function and can be used as biomarkers for risk of macrovascular complications in diabetics [5] [20] . In this study, mean absolute platelet count of the type 2, Gestational diabetics and control subjects was the major parameter of concern. Similarly, in a study carried out by Obeagu et al. [24] in South East Nigeria, absolute platelet counts were found to be less in male and female diabetics compared to male and female controls, respectively with p-value ˃0.05. Nneka et al. [18] reported concurring results in the same region. Zuberi et al. [4] found relating results from Pakistan; Elnour and Muddathir [7] also showed concurring observations among pregnant Sudanese women.
The platelet counts of diabetic patients cutting across genders and types of diabetes correlates positively with the levels glycaemic control defined by the level of blood sugar of such patients [25] .Our study shows statistically significant decrease (p˂0.05) in the mean absolute platelet counts of patients with type 2 diabetes (315.37±56.13) when compared to patients with GDM (325.82±56.78). Previous studies on platelet indices of diabetes in this locality did not compare counts among the types of diabetes. Raised platelet counts in GDM may be linked to some diabetes induced platelet related complications associated with mortality and morbidity in pregnancy.
V. Conclusion
Routine platelet counts result is a good index for evaluation thrombotic function of diabetic patients, but more useful in conjunction with testing the overall functionality of the coagulation cascades.
